Proteostasis of islet amyloid polypeptide: a molecular perspective of risk factors and protective strategies for type II diabetes

D Milardi, E Gazit, SE Radford, Y Xu… - Chemical …, 2021 - ACS Publications
The possible link between hIAPP accumulation and β-cell death in diabetic patients has
inspired numerous studies focusing on amyloid structures and aggregation pathways of this …

Implications of peptide assemblies in amyloid diseases

PC Ke, MA Sani, F Ding, A Kakinen, I Javed… - Chemical Society …, 2017 - pubs.rsc.org
Neurodegenerative disorders and type 2 diabetes are global epidemics compromising the
quality of life of millions worldwide, with profound social and economic implications. Despite …

Role of zinc homeostasis in the pathogenesis of diabetes and obesity

A Fukunaka, Y Fujitani - International journal of molecular sciences, 2018 - mdpi.com
Zinc deficiency is a risk factor for obesity and diabetes. However, until recently, the
underlying molecular mechanisms remained unclear. The breakthrough discovery that the …

Islet amyloid polypeptide, islet amyloid, and diabetes mellitus

P Westermark, A Andersson… - Physiological …, 2011 - journals.physiology.org
Islet amyloid polypeptide (IAPP, or amylin) is one of the major secretory products of β-cells of
the pancreatic islets of Langerhans. It is a regulatory peptide with putative function both …

Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective

JR Brender, S Salamekh… - Accounts of chemical …, 2012 - ACS Publications
The aggregation of proteins is tightly controlled in living systems, and misfolded proteins are
normally removed before aggregation of the misfolded protein can occur. But for reasons not …

Misfolded proteins in Alzheimer's disease and type II diabetes

AS DeToma, S Salamekh, A Ramamoorthy… - Chemical Society …, 2012 - pubs.rsc.org
This tutorial review presents descriptions of two amyloidogenic proteins, amyloid-β (Aβ)
peptides and islet amyloid polypeptide (IAPP), whose misfolding propensities are implicated …

Evidence of cosecretion of islet amyloid polypeptide and insulin by β-cells

SE Kahn, DA D'Alessio, MW Schwartz, WY Fujimoto… - Diabetes, 1990 - Am Diabetes Assoc
Islet amyloid polypeptide (IAPP) has been identified as the major constituent of the
pancreatic amyloid of non-insulin-dependent diabetes mellitus (NIDDM) and is also present …

Solute carrier transporters as potential targets for the treatment of metabolic disease

T Schumann, J König, C Henke, DM Willmes… - Pharmacological …, 2020 - ASPET
The solute carrier (SLC) superfamily comprises more than 400 transport proteins mediating
the influx and efflux of substances such as ions, nucleotides, and sugars across biological …

The flavanol (−)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against …

F Meng, A Abedini, A Plesner, CB Verchere… - Biochemistry, 2010 - ACS Publications
Islet amyloid polypeptide (IAPP, amylin) is the major protein component of the islet amyloid
deposits associated with type 2 diabetes. The polypeptide lacks a well-defined structure in …

Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis

SB Padrick, AD Miranker - Biochemistry, 2002 - ACS Publications
Islet amyloid polypeptide (IAPP) contributes to the pathogenesis of type II diabetes by
depositing as cytotoxic amyloid fibers in the endocrine pancreas. Fiber formation occurs with …